NCT05522049

Brief Summary

Videolaryngoscopy-guided intubation has become widespread as a means of preventing major complications relating to airway management by improving the glottic view, increasing the first attempt success rate, likely reduce rates of hypoxemic events, while reducing the rate of airway trauma. However, as randomized controlled studies in patients with anticipated difficult intubation undergoing ear nose and throat (ENT) or oral and maxillofacial (OMF) surgery are lacking, it is still unknown if hyperangulated blades improve glottic view and if their use translates into faster intubation. The primary aim of this randomized controlled trial is to compare the percentage of glottic opening (POGO) between hyperangulated blades and Macintosh blades in patients with expected difficult intubation undergoing ENT or OMF surgery who require transoral tracheal intubation. Secondary aims are to compare secondary outcome measures such as time variables, indicators for difficult and successful intubation, number of attempts, view conditions, difficult airway classifications and adverse events between both blade types.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 30, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

September 26, 2023

Status Verified

September 1, 2023

Enrollment Period

10 months

First QC Date

August 22, 2022

Last Update Submit

September 24, 2023

Conditions

Keywords

Airway managementHyperangulated bladeMacintosh blade

Outcome Measures

Primary Outcomes (1)

  • Percentage of glottic opening (POGO)

    Grading of the best view obtained during laryngoscopy (%)

    1 hour

Secondary Outcomes (16)

  • Time to successful tracheal intubation (seconds)

    1 hour

  • Time to successful first attempt intubation (seconds)

    1 hour

  • Cormack-Lehane grade

    1 hour

  • Impaired view (vocal cords cannot be visualized by laryngoscopy)

    1 hour

  • Difficult laryngoscopy

    1 hour

  • +11 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Tracheal intubation facilitated by a hyperangulated videolaryngoscope (C-MAC D-Blade)

Device: hyperangulated videolaryngoscope

Control group

ACTIVE COMPARATOR

Tracheal intubation facilitated by a videolaryngoscope with a Macintosh type blade (C-MAC)

Device: Macintosh videolaryngoscope

Interventions

Intubation using a hyperangulated videolaryngoscope

Also known as: C-MAC D-Blade, Storz
Intervention group

Intubation using a Macintosh videolaryngoscope

Also known as: C-MAC, Storz
Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring general anesthesia with transoral tracheal intubation for elective ear, nose and throat or maxillofacial surgery
  • Expected difficult intubation
  • Age ≥ 18

You may not qualify if:

  • Pregnant or breastfeeding woman
  • Planned awake tracheal intubation (without deep anesthesia or neuromuscular blocking agents)
  • Required transnasal tracheal intubation (e.g. for surgical reasons)
  • Special tubes required for surgical reasons ( e.g. double lumen tube)
  • Denial of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Hamburg-Eppendorf

Hamburg, 20246, Germany

Location

Study Officials

  • Martin Petzoldt, MD

    Universitätsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2022

First Posted

August 30, 2022

Study Start

October 17, 2022

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

September 26, 2023

Record last verified: 2023-09

Locations